Multimodal imaging with PET, fMRI and genetic research;Multimodale bildgebung mit PET, fMRI und genetischen untersuchungen

Fortschritte der Neurologie Psychiatrie

Volumn 76, Issue 5, 2008, Pages 278-285

  Wrase, J ^a,b   Reimold, M ^b,c   Beck, A ^a   Heinz, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Gleichrangiger Beitrag ^*

Author keywords

fMRI; Genetic effects; Multimodal imaging; PET; SPECT

Indexed keywords

CARFENTANIL; DOPAMINE; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; NEUROTRANSMITTER TRANSPORTER; RADIOLIGAND; SEROTONIN; SEROTONIN TRANSPORTER; TRACER;

ADD ON THERAPY; ALCOHOL CONSUMPTION; ALLELE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PUTAMEN; QUANTITATIVE ANALYSIS; RECEPTOR AFFINITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN; DIAGNOSTIC IMAGING; HISTOLOGY; METABOLISM; METHODOLOGY; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; SCINTISCANNING;

BRAIN; DIAGNOSTIC IMAGING; GENETICS; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROLOGY; NEUROTRANSMITTER TRANSPORT PROTEINS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, NEUROTRANSMITTER; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 45849134120     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038178     Document Type: Article

References (33)

1. Heinz A, Smolka MN, Braus DF, Wrase J, Beck A, Flor H, Mann K, Schumann G, Büchel C, Hariri AR, Weinberger DR. Serotonin transporter genotype (5-HTTLPR): Effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry 2007; 61(8): 1011-1014
2. Heinz A, Jones DW, Corey JG, Knable MB, Lee KS, Saunders RC, Weinberger DR. Analysis of the metabolites of [I-123]β-CIT in plasma of humans and non-human primates. Synapse 1997; 25: 306-308
3. Hummerich R, Reischl G, Ehrlichmann W, Machulla HJ, Heinz A, Schloss P. DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer. J Neurochem 2004; 90: 1218-1226
4. Heinz A, Jones DW, Zajicek K, Gorey JG, Juckel G, Higley JD, Weinberger DR. Depletion and restoration of endogenous monoamines affects beta-CIT binding to serotonin but not dopamine transporters in non-human primates. J Neural Transm Suppl 2004; 68: 29-38
5. Hietala J, West C, Sylvälahti E, Nygren K, Lehikoinen P, Sonninen P, Ruotsalainen U. Striatal dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacol 1994; 116: 285-290
6. Lamelle M, Wallace A, Seibyl JP, Baldwin M, Zea-Ponce Y, Zoghbi SS, Neumeyer JL, Chamey DS, Hoffer PB, Innis RB. Graphical, kinetic, and equilibrium analysis of in vivo [I-123]β-CIT binding to dopamine transporters in healthy human subjects. J Cerebr Blood Flow Metab 1994; 14: 982-994
7. Fisher RE, Morris ED, Alpert NM, Fischman AJ. In vivo imaging of neuromodulatory synaptic transmission using PET: a review of relevant neurophysiology. Hum Brain Map 1995; 3: 24-34
8. Heinz A Siessmeier T, Wrase J, Buchholz HG, Grunder G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3-receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psy-chiatry 2005; 162: 1515-1512
9. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, Kegeles L, Talbot P, Evans S, Krystal J, Lamelle M, Abi-Dargham A. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 2005 Nov 15; 58: 779-786
10. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA Li X, Jabs EW, Uhl GR. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14: 1104-1106
11. Sano A Kondoh K, Kakimoto Y, Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 1993; 91: 405-406
12. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 1997; 1: 299-304
13. Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 1998; 155: 474-478
14. Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacol 1994; 11: 195-200
15. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, Sirota LA, Marcus SE, Greenberg BD, Lucas IVFR, Benjamin J, Murphy DL, Hamer DH. A genetic association for cigarette smoking behaviour. Health Psychol 1999; 18: 7-13
16. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacol 2000; 22: 133-139
17. Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DF, Schumann G, Machulla HJ, Bares R, Mann K. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 2005; 62: 57-64
18. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531
19. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicit. Biol Psychiatry 2000; 47: 643-649
20. Heinz A Batra A. Neurobiologie der Alkohol- und Nikotinabhängigkeit. Kohlhammer, Stuttgart, (2003)
21. Nakamura M, Ueno S, Sana A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000; 5: 32-38
22. Reimold M, Smolka MN, Schumann G, Zimmer A, Wrase J, Mann K, Hu XZ, Goldman D, Reischl G, Solbach C, Machulla HJ, Bares R, Heinz A. Serotonin transporter genotype interacts with raphe serotonin transporter availability. J Neural Transm 2008 (in press)
23. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400-403
24. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828-834
25. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grusser SM, Flor H, Schumann G, Mann K, Buchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005; 8: 20-21
26. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M. Reduced central serotonin transporters in alcoholism. Am J Psychiatry 1998; 155: 1544-1549
27. Bennett AJ, Lesch KP, Heils A, Long JC, Lorenz JG, Shoaf SE, Champoux M, Suomi SJ, Linnoila MV, Higley JD. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 2002; 7: 118-122
28. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-389
29. Smolka MN, Schumann G, Wrase J, Grusser SM, Flor H, Mann K, Braus DF, Goldman D, Buchel C, Heinz A. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 2005; 25: 836-842
30. Smolka MN, Buhler M, Schumann G, Klein S, Hu X-Z, Moayer M, Zimmer A, Wrase J, Flor H, Mann K, Braus DF, Goldman D, Heinz A. Gene-gene effects on central processing of aversive stimuli. Molecular Psychiatry 2007; 12 (3): 307-317
31. Siessmeier T, Kienast T, Wrase J, Larsen JL, Braus DF, Smolka MN, Buchholz HG, Schreckenberger M, Rosch F, Camming P, Mann K, Bartenstein P, Heinz A. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. Eur J Neurosci 2006; 24: 305-313
32. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser SM, Flor H, Braus DF, Buchholz HG, Grunder G, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 2004; 161 (10): 1783-1789 Erratum in: Am J Psychiatry 2004; 161: 2344
33. Grusser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF, Heinz A. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 2004; 175: 296-302